RESUMEN
INTRODUCTION AND OBJECTIVES: This article presents the annual activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) for the year 2022. METHODS: All Spanish centers with catheterization laboratories were invited to participate. Data were collected online and were analyzed by an external company in collaboration with the members of the board of the ACI-SEC. RESULTS: A total of 111 centers participated. The number of diagnostic studies increased by 4.8% compared with 2021, while that of percutaneous coronary interventions (PCI) remained stable. PCIs on the left main coronary artery increased by 22%. The radial approach continued to be preferred for PCI (94.9%). There was an upsurge in the use of drug-eluting balloons, as well as in intracoronary imaging techniques, which were used in 14.7% of PCIs. The use of pressure wires also increased (6.3% vs 2021) as did plaque modification techniques. Primary PCI continued to grow and was the most frequent treatment (97%) in ST-segment elevation myocardial infarction. Most noncoronary procedures maintained their upward trend, particularly percutaneous aortic valve implantation, atrial appendage closure, mitral/tricuspid edge-to-edge therapy, renal denervation, and percutaneous treatment of pulmonary arterial disease. CONCLUSIONS: The Spanish cardiac catheterization and coronary intervention registry for 2022 reveals a rise in the complexity of coronary disease, along with a notable growth in procedures for valvular and nonvalvular structural heart disease.
Asunto(s)
Cardiología , Enfermedad de la Arteria Coronaria , Intervención Coronaria Percutánea , Humanos , Cateterismo Cardíaco , Sistema de RegistrosRESUMEN
BACKGROUND: The Watchman FLX is a device upgrade of the Watchman 2.5 that incorporates several design enhancements intended to simplify left atrial appendage occlusion (LAAO) and improve procedural outcomes. This study compares peri-procedural results of LAAO with Watchman FLX (Boston Scientific, Marlborough, Massachusetts) in centers with varying degrees of experience with the Watchman 2.5 and Watchman FLX. METHODS: Prospective, multicenter, "real-world" registry including consecutive patients undergoing LAAO with the Watchman FLX at 26 Spanish sites (FLX-SPA registry). Implanting centers were classified according to the center's prior experience with the Watchman 2.5. A further division of centers according to whether or not they had performed ≤ 10 or > 10Watchman FLX implants was prespecified at the beginning of the study. Procedural outcomes of institutions stratified according to their experience with the Watchman 2.5 and FLX devices were compared. RESULTS: 359 patients [mean age 75.5 (SD8.1), CHA2DS2-VASc 4.4 (SD1.4), HAS-BLED 3.8(SD0.9)] were included. Global success rate was 98.6%, successful LAAO with the first selected device size was achieved in 95.5% patients and the device was implanted at first attempt in 78.6% cases. There were only 9(2.5%) major peri-procedural complications. No differences in efficacy or safety results according to the centers previous experience with Watchman 2.5 and procedural volume with Watchman FLX existed. CONCLUSIONS: The Watchman FLX attains high procedural success rates with complete LAA sealing in unselected, real-world patients, along with a low incidence of peri-procedural complications, regardless of operators experience with its previous device iteration or the number of Watchman FLX devices implanted.
RESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Anciano , Síndrome Coronario Agudo/complicaciones , Infecciones por Coronavirus/complicaciones , Trombosis Coronaria/complicaciones , Choque/complicaciones , Resultado Fatal , Electrocardiografía/métodos , Infarto del Bazo/complicaciones , Embolia Pulmonar/complicaciones , Isquemia Mesentérica/complicacionesAsunto(s)
Síndrome Coronario Agudo/etiología , Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Choque Cardiogénico/etiología , Síndrome Coronario Agudo/diagnóstico , Síndrome Coronario Agudo/terapia , Anciano , COVID-19 , Trombosis Coronaria/diagnóstico , Trombosis Coronaria/etiología , Trombosis Coronaria/terapia , Resultado Fatal , Humanos , Masculino , Pandemias , Choque Cardiogénico/diagnóstico , Choque Cardiogénico/terapiaRESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Alphainfluenzavirus/patogenicidad , Choque Cardiogénico/complicaciones , Choque Cardiogénico/diagnóstico , Taponamiento Cardíaco/complicaciones , Pericarditis/complicaciones , Factores de Riesgo , Choque Séptico/diagnóstico por imagen , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/diagnóstico por imagen , Derrame Pericárdico/complicaciones , Electrocardiografía/métodos , Radiografía Torácica/métodos , Neuraminidasa/uso terapéutico , Colchicina/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéuticoAsunto(s)
Acidosis Láctica/etiología , Taponamiento Cardíaco/etiología , Gripe Humana/complicaciones , Miocarditis/complicaciones , Pericarditis/complicaciones , Choque Cardiogénico/etiología , Acidosis Láctica/terapia , Taponamiento Cardíaco/diagnóstico por imagen , Taponamiento Cardíaco/terapia , Progresión de la Enfermedad , Ecocardiografía , Electrocardiografía , Femenino , Humanos , Virus de la Influenza A , Gripe Humana/diagnóstico , Persona de Mediana Edad , Miocarditis/diagnóstico , Pericardiocentesis , Pericarditis/diagnóstico , Radiografía Torácica , Choque Cardiogénico/diagnóstico , Choque Cardiogénico/terapia , Tomografía Computarizada por Rayos XRESUMEN
Myxoma is the most common primary tumor of the heart. It is uncommon for these tumors to become infected and, at times, clinical presentation is no different from that of an uninfected myxoma. We describe the case of a 58-year-old woman with a previous pharyngeal infection that developed into infection of a left atrial myxoma and which was complicated by systemic embolism affecting the lower limbs. Streptococcus oralis was identified in blood cultures and embolic material. The tumor was resected and the patient's subsequent clinical evolution was uneventful. The incidence of infected myxoma is very low. A review of the literature based on individual case reports is presented.
Asunto(s)
Neoplasias Cardíacas/complicaciones , Mixoma/complicaciones , Infecciones Estreptocócicas/complicaciones , Streptococcus oralis , Femenino , Atrios Cardíacos , Humanos , Persona de Mediana EdadRESUMEN
El mixoma es el tumor primario más frecuente que afecta al corazón. La infección de estos tumores es infrecuente y, en ocasiones, su presentación clínica es indistinguible de un mixoma no infectado. Describimos el caso de una mujer de 58 años con una infección faríngea previa que desarrolló infección sobre un mixoma auricular izquierdo, complicado con embolia sistémica en los miembros inferiores. Se aisló Streptococcus oralis en los hemocultivos y en el material embólico. El tumor se resecó y la evolución clínica posterior resultó sin incidencias. La frecuencia del mixoma infectado es muy baja y una revisión de la bibliografía se ha de basar en los casos aislados publicados
Myxoma is the most common primary tumor of the heart. It is uncommon for these tumors to become infected and, at times, clinical presentation is no different from that of an uninfected myxoma. We describe the case of a 58-year-old woman with a previous pharyngeal infection that developed into infection of a left atrial myxoma and which was complicated by systemic embolism affecting the lower limbs. Streptococcus oralis was identified in blood cultures and embolic material. The tumor was resected and the patient's subsequent clinical evolution was uneventful. The incidence of infected myxoma is very low. A review of the literature based on individual case reports is presented